首页> 美国卫生研究院文献>The Indian Journal of Medical Research >Enhanced resistance to fluoroquinolones in laboratory-grown mutants clinical isolates of Shigella due to synergism between efflux pump expression mutations in quinolone resistance determining region
【2h】

Enhanced resistance to fluoroquinolones in laboratory-grown mutants clinical isolates of Shigella due to synergism between efflux pump expression mutations in quinolone resistance determining region

机译:由于外排泵表达与喹诺酮耐药性决定区突变之间的协同作用实验室培养的志贺氏菌突变体和临床分离株对氟喹诺酮类药物的耐药性增强

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background & objectives:There is a worldwide emergence of fluoroquinolone resistance in Shigella species. To understand the molecular mechanisms associated with fluoroquinolone resistance, naturally occurring fluoroquinolone-resistant strains and laboratory-induced spontaneous mutants of Shigella spp. were used and the relative contributions of acrAB-tolC efflux pumps, gyrase and topoisomerase target gene mutations towards fluoroquinolone resistance were determined.
机译:背景与目标:志贺氏菌属物种在全球范围内出现了对氟喹诺酮类药物的耐药性。要了解与氟喹诺酮耐药性,天然存在的氟喹诺酮耐药菌株和实验室诱导的志贺氏菌属自发突变体相关的分子机制。使用并确定了acrAB-tolC外排泵,促旋酶和拓扑异构酶靶基因突变对氟喹诺酮耐药性的相对贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号